ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pozen To Buy Tribute And Move To Ireland

by Ann M. Thayer
June 15, 2015 | APPEARED IN VOLUME 93, ISSUE 24

Chapel Hill, N.C.-based Pozen is acquiring Canada’s Tribute Pharmaceuticals for about $146 million. After the transaction is completed, the combined specialty drug firm will be called Aralez Pharmaceuticals and have headquarters in Ireland. To support the new company, the health care investment firm Deerfield and other investors have committed up to $350 million. On June 1, Pozen announced that its founder and chairman, John R. Plachetka, was leaving the firm immediately.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment